Allogeneic hematopoietic cell transplantation in multiple myeloma
Autologous hematopoietic cell transplantation in multiple myeloma
Clinical features, laboratory manifestations, and diagnosis of multiple myeloma
Overview of the management of multiple myeloma
Diagnosis and management of solitary extramedullary plasmacytoma
Diagnosis and management of solitary plasmacytoma of bone
Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)
Evaluating response to treatment of multiple myeloma
Selection of initial chemotherapy for symptomatic multiple myeloma
Management of multiple myeloma in resource-poor settings
Diagnosis of monoclonal gammopathy of undetermined significance
Pathobiology of multiple myeloma
Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases
Clinical features, evaluation, and diagnosis of kidney disease in multiple myeloma and other monoclonal gammopathies
Treatment of relapsed or refractory multiple myeloma
Treatment and prognosis of kidney disease in multiple myeloma and other monoclonal gammopathies
Treatment of the complications of multiple myeloma
Epidemiology, pathogenesis, and etiology of kidney disease in multiple myeloma and other monoclonal gammopathies
The use of osteoclast inhibitors in patients with multiple myeloma
The following organizations also provide reliable health information.
The most common side effect of topical corticosteroid use is skin atrophy. All topical steroids can induce atrophy, but higher potency steroids, occlusion, thinner skin, and older patient age increase the risk. The face, the backs of the hands, and intertriginous areas are particularly susceptible. Resolution often occurs after discontinuing use of these agents, but it may take months. Concurrent use of topical tretinoin (Retin-A) % may reduce the incidence of atrophy from chronic steroid applications. 30 Other side effects from topical steroids include permanent dermal atrophy, telangiectasia, and striae.
I won’t lie and tell you that I haven’t thought about trying the protocol again. The fact is I have had fairly severe osteoporosis since my 30’s, including some bad breaks. Steroids are very hard on bones. I also have digestive problems, and take high doses of indomethacin – a drug known for causing serious digestive side effects. Adding steroids to the heap isn’t something any of my subsequent doctors and specialists have been comfortable with trying as it could be dangerous. We’ve tried injectables and smaller doses of prednisone, with far less spectacular results, but to date nothing near the experience I had with the IV.
Don't miss a thing!
Sign up for emails from : Thanks! You're all set!